- Long-term Disease
- Short-term Disease
Pediatrics Market Size was valued at USD 162.4 billion in 2022 and is poised to grow at a CAGR of 4.5% from 2023-29. Pediatrics is a branch of medicine related to the medical treatment and care of infants and children. According to the Federal Food, Drug, and Cosmetic Act (FD&C Act), Pediatrics patients aged should be 21 or younger at the time of their diagnosis or treatment. Pediatric patients can be categorized as neonates (from birth through the first 28 days of life), infants (29 days to less than 2 years), children (2 years to less than 12 years), adolescents (12 years to less than 22). Some medicines and treatments are specially designed for children others are borrowed from adult applications with the significant change in dosage and other factors. The increasing number of deaths due to various diseases, infections, and malnutrition is driving the growth of the global Pediatrics market. According to UNICEF data, 5 million children under 5 years of age died in 2020 which means 13,800 children under the age of 5 died every day in 2020 due to infectious diseases, including pneumonia, diarrhoea, and malaria along with premature birth and birth-related complications. Moreover, the rise in research and development for new Pediatrics medicines & therapies, and the rise in government support and initiatives will further drive the market. The Pediatrics market is expected to grow significantly due to the prevalence of chronic illness, lower immunity, and a rise in injury-related cases that are more common in children and teenagers. North America is dominating the market based on the region due to rising concerns about child care. Asia Specific regions are likely to register the highest CAGR due to rising premature birth & related complications, malnutrition, rising awareness, and the increasing number of companies investing in Pediatrics medications.
Study Period
2024-2030Base Year
2023CAGR
4.50%Largest Market
Asia-PacificFastest Growing Market
North America
The growing prevalence of chronic disorders, diarrhea, and injury in children and teenagers is increasing rapidly. These key driving factors are expected to fuel the growth of the global Pediatrics market. According to the Centers for Disease Control and Prevention, 1 in 6 U.S. children aged 2–8 years (17.4%) had a diagnosed mental, behavioral, or developmental disorder. However, the prevalence of autism and attention deficit hyperactivity disorder (ADHD) has continued to rise worldwide. For instance, ADHD, anxiety problems, behavior problems, and depression are the most occurred mental disorders in children. ADHD 9.8% (6.0 million), Anxiety 9.4% (5.8 million), Behavior problems 8.9% (5.5 million), Depression 4.4% (2.7 million) among children age 3-17. So, the demand for pediatric healthcare grew tremendously in 2021.
By Period Of Disease
By Therapeutics
By Treatment
The pediatrics market is projected to expand at a CAGR of 4.5% during the forecast period
Novartis, Abbott, GlaxoSmithKline, AstraZeneca, Johnson & Johnson, Sanofi LLC, Eli Lilly, Merck and Company, AxcanPharma
North America is the fastest-growing region for pediatrics market
1. Executive Summary |
2. Global Pediatrics Market Introduction |
2.1. Global Pediatrics Market Taxonomy |
2.2. Global Pediatrics Market Definitions |
2.2.1. Period of Disease |
2.2.2. Therapeutics |
2.2.3. Treatment |
2.2.4. By Region |
3. Global Pediatrics Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Pediatrics Market Dynamic Factors - Impact Analysis |
3.6. Global Pediatrics Market Competition Landscape |
3.7. Epidemiology |
4. Global Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Pediatrics Market, By Period of Disease, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1. Long-term Disease |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Short-term Disease |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Pediatrics Market, By Therapeutics, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.1. Asthma & Allergies |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cardiology |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Gastroenterology |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Diabetes |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Obesity |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Cerebral palsy |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Chronic illness |
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Others |
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
7. Global Pediatrics Market, By Treatment, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.1. Medication |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Immunotherapy |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Dietary restrictions |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Surgery |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Others |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Pediatrics Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia-Pacific |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Latin America |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Middle East and Africa |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
8.6. Global Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Region, 2023 - 2029 |
9. North America Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
9.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Long-term Disease |
9.1.2. Short-term Disease |
9.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Asthma & Allergies |
9.2.2. Cardiology |
9.2.3. Gastroenterology |
9.2.4. Diabetes |
9.2.5. Obesity |
9.2.6. Cerebral palsy |
9.2.7. Chronic illness |
9.2.8. Others |
9.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Medication |
9.3.2. Immunotherapy |
9.3.3. Dietary restrictions |
9.3.4. Surgery |
9.3.5. Others |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.4.1. USA |
9.4.2. Canada |
9.5. North America Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029 |
9.6. North America Pediatrics Market Dynamics Trends |
10. Europe Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
10.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Long-term Disease |
10.1.2. Short-term Disease |
10.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Asthma & Allergies |
10.2.2. Cardiology |
10.2.3. Gastroenterology |
10.2.4. Diabetes |
10.2.5. Obesity |
10.2.6. Cerebral palsy |
10.2.7. Chronic illness |
10.2.8. Others |
10.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Medication |
10.3.2. Immunotherapy |
10.3.3. Dietary restrictions |
10.3.4. Surgery |
10.3.5. Others |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.4.1. Germany |
10.4.2. UK |
10.4.3. France |
10.4.4. Spain |
10.4.5. Italy |
10.4.6. Rest of Europe |
10.5. Europe Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029 |
10.6. Europe Pediatrics Market Dynamics Trends |
11. Asia-Pacific Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
11.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Long-term Disease |
11.1.2. Short-term Disease |
11.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Asthma & Allergies |
11.2.2. Cardiology |
11.2.3. Gastroenterology |
11.2.4. Diabetes |
11.2.5. Obesity |
11.2.6. Cerebral palsy |
11.2.7. Chronic illness |
11.2.8. Others |
11.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Medication |
11.3.2. Immunotherapy |
11.3.3. Dietary restrictions |
11.3.4. Surgery |
11.3.5. Others |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.4.1. China |
11.4.2. India |
11.4.3. Japan |
11.4.4. ASEAN |
11.4.5. Australia & New Zealand |
11.4.6. Rest of Asia-Pacific |
11.5. Asia-Pacific Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029 |
11.6. Asia-Pacific Pediatrics Market Dynamics Trends |
12. Latin America Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
12.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Long-term Disease |
12.1.2. Short-term Disease |
12.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Asthma & Allergies |
12.2.2. Cardiology |
12.2.3. Gastroenterology |
12.2.4. Diabetes |
12.2.5. Obesity |
12.2.6. Cerebral palsy |
12.2.7. Chronic illness |
12.2.8. Others |
12.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Medication |
12.3.2. Immunotherapy |
12.3.3. Dietary restrictions |
12.3.4. Surgery |
12.3.5. Others |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Brazil |
12.4.2. Mexico |
12.4.3. Rest of Latin America |
12.5. Latin America Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029 |
12.6. Latin America Pediatrics Market Dynamics Trends |
13. Middle East and Africa Pediatrics Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
13.1. Period of Disease Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.1.1. Long-term Disease |
13.1.2. Short-term Disease |
13.2. Therapeutics Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) |
13.2.1. Asthma & Allergies |
13.2.2. Cardiology |
13.2.3. Gastroenterology |
13.2.4. Diabetes |
13.2.5. Obesity |
13.2.6. Cerebral palsy |
13.2.7. Chronic illness |
13.2.8. Others |
13.3. Treatment Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Medication |
13.3.2. Immunotherapy |
13.3.3. Dietary restrictions |
13.3.4. Surgery |
13.3.5. Others |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Gulf Cooperation Council (GCC) Countries |
13.4.2. South Africa |
13.4.3. Rest of MEA |
13.5. MEA Pediatrics Market - Opportunity Analysis Index, By Period of Disease, By Therapeutics, By Treatment, and Country, 2023 - 2029 |
13.6. MEA Pediatrics Market Dynamics Trends |
14. Competition Landscape |
14.1. Strategic Dashboard of Top Market Players |
14.2. Company Profiles (Introduction, Financial Analysis, Key Period of Diseases, Key Developments, Strategies, and SWOT Analysis) |
14.2.1. Novartis |
14.2.2. Abbott |
14.2.3. GlaxoSmithKline |
14.2.4. AstraZeneca |
14.2.5. Johnson & Johnson |
14.2.6. Sanofi LLC |
14.2.7. Eli Lilly |
14.2.8. Merck and Company |
14.2.9. AxcanPharma |
15. Research Methodology |
16. Key Assumptions and Acronyms |